Outline Predisposition to Idiopathic Pulmonary What is IPF? - - PowerPoint PPT Presentation

outline
SMART_READER_LITE
LIVE PREVIEW

Outline Predisposition to Idiopathic Pulmonary What is IPF? - - PowerPoint PPT Presentation

11/5/2016 Outline Predisposition to Idiopathic Pulmonary What is IPF? Fibrosis (IPF) Insights into Pathogenesis Epidemiology of IPF Genetic predisposition Initiation of IPF Epithelial cell dysfunction Paul Wolters


slide-1
SLIDE 1

11/5/2016 1

What is IPF? Insights into Pathogenesis

Paul Wolters Professor University of California, San Francisco

Outline

  • Predisposition to Idiopathic Pulmonary

Fibrosis (IPF)

– Epidemiology of IPF – Genetic predisposition

  • Initiation of IPF

– Epithelial cell dysfunction

  • Telomere dysfunction
  • Propagation of IPF

– Pathologic Matrix

IPF: Pathology IPF: Pathology

slide-2
SLIDE 2

11/5/2016 2

IPF: Survival

/IPF

Predisposition to IPF: Epidemiology Risk Factors for IPF

  • Tobacco smoking
  • Working in dusty environments
  • Gastroesophageal reflux disease
  • Aging
  • Genetic predisposition

IPF is a Disease Associated With Aging

Ley, Clin Epidemiol 2013

slide-3
SLIDE 3

11/5/2016 3

Population is Aging Prevalence of IPF is Increasing

Raghu et al, Lancet Resp Med 2014

Predisposition to IPF: Genetics Genetics: Dyskeratosis Congenita

  • Skin hyperpigmentation
  • Nail dystrophy
  • Oral leukoplakia
  • Liver cirrhosis
  • Bone marrow failure
  • Lung fibrosis

Caused by mutations in: TERT, TERC, proteins in shelterin complex

slide-4
SLIDE 4

11/5/2016 4

Telomerase Mutations and Lung Fibrosis

  • Patients with Dyskeratosis

Congenita have mutations in TERT, TERC, DKC1 and lung fibrosis

  • TERT/TERC mutations are

found in 8-15% of patients with FPF, 5% with IPF.

  • Lung fibrosis is found in

40% of patients with TERT/TERC mutations.

Diaz de Leon et al, Plos One ‘10 Alder et al, PNAS ‘08 Armanios et al, New Engl J Med ‘07 Genes Associated with Familial ILD SPA SPC TERT TERC RTEL1 PARN ABCA3 TINF2 DKC1

Genetics: Familial IPF

Nogee et al, NEJM ‘01 Thomas et al, Am J Resp Crit Care Med ‘02 Armanios et al, New Engl J Med ’07 Tsakiri et al, PNAS ‘07 Alder et al, PNAS ’08 Wang et al, Am J Hum Genet ‘09 Diaz de Leon et al, Plos One ’10 Kropski et al, Chest 2014 Stuart et al, Nat Genetics ’15 Cogan et al, Am J Resp Crit Care Med ‘15

Genetics: Sporadic IPF

Fingerlin et al, Nat Gen 2013

1616 pts with IPF 4618 controls

MUC5B Variant

  • MUC5B: Glycoprotein encoded by the MUC5B gene.
  • Expressed mostly in distal airways

– Increased expression in honeycomb cyst of IPF lung

  • Odds ratio for developing disease

– Heterozygous (GT)= 6.8-9.0 – Homozygous (TT)= 21-22

  • Genetic association replicated in many studies.
  • Variant causes increased MUC5B expression. Unknown

how this contributes to disease pathogenesis.

slide-5
SLIDE 5

11/5/2016 5

IPF Genetic Predisposition: Summary

Genes Associated with Familial ILD Genes Associated with Sporadic IPF SPA MUC5B SPC DSP TERT TERT TERC TERC RTEL1 OBFC1 PARN DPP9 ABCA3 FAM13A TINF2 TOLLIP DKC1

Pulmonary fibrosis genetic studies overwhelmingly implicate epithelial cells and telomere dysfunction in disease process

Initiation of IPF: Epithelial cell Telomere Dysfunction

Telomeres/Telomerase

  • Telomere: Repetitive DNA

sequence at end of chromosomes, which protect the end of chromosomes from deterioration.

  • Maintained by telomerase
  • Telomeres progressively

shorter with each cell division.

  • Cells with short telomeres

either senesce or die.

Peripheral Blood Leukocyte Telomeres Shorten with Aging

Vaziri et al. AJHG (1995) Cawthon et al. Lancet (2005)

slide-6
SLIDE 6

11/5/2016 6

Lung Telomeres Shorten Relatively More Than other Organs

Gardner et al, J Gerontol Biol Soc 2007

Peripheral Blood Leukocyte Telomeres Length Predicts IPF Patient Survival

Stuart et al, Lancet Resp Med 2014

Time to Death

Telomeres are Shortened in IPF Type II Cells

Alder J K et al. PNAS 2008 Kropski et al. Am J Resp Crit Care Med 2015 Wolters, unpublished

Epithelial Cell Senescence is Unique to IPF

IPF Normal HP SSc Disayabutr et al, PLOSONE 2016

slide-7
SLIDE 7

11/5/2016 7

Modeling Telomere Dysfunction

Modeling Telomere Dysfunction in Mice

  • Mouse telomeres are 5-10x longer than

human telomeres

  • Deletion of TERT or TERC do not successfully

model diseases of telomere dysfunction

– Mice become sterile before diseases manifest.

Blood 2012

slide-8
SLIDE 8

11/5/2016 8

Type II Cell-Specific Telomere Dysfunction Causes Lung Fibrosis

Naikawadi et al, JCI Insight 2016

Type II Cell-Specific Telomere Dysfunction Causes Lung Fibrosis

**p< 0.01 Naikawadi et al, JCI Insight 2016

10 20 30 40 50

TRF1F/F SPC-creTRF1F/F

*

3M 8M Tamox Active TGF-β1 (pg/ml)

Lung Remodeling is Associated with Increased Levels of Active TGFβ

Propagation of IPF : Pathologic Matrix

slide-9
SLIDE 9

11/5/2016 9

IPF Fibroblast Biology

  • IPF fibroblasts are different from “normal” fibroblasts.

– Resistant to apoptosis – Make more collagen – More invasive

  • Fibroblast phenotype differs when cultured on matrix of

different stiffness (Young’s elastic modulus).

– Stiffness of lung: 1 kPa – Stiffness of plastic: 2-4 GPa

  • Fibroblasts alter phenotype when cultured on matrix

derived from IPF lung vs. normal lung

Decellularized lung

Booth et al, AJRCCM, 2012

IPF Extracellular Matrix Has a Unique Composition

Higher in IPF Matrix Lower in IPF Matrix Booth et al, AJRCCM, 2012

IPF Matrix is Stiffer than Normal

Booth et al, AJRCCM, 2012

slide-10
SLIDE 10

11/5/2016 10

Fibrotic Matrix Activates a Positive Feedback

Parker et al JCI 2014

IPF Pathogenesis: Summary

ER Stress AECII turnover

Normal TII Cell TII Cell replication Telomere shortening TII Cell replication Telomere Shortening

Misfolded protein Infections Genetic predisposition (SPC, TERT, TERC, MUC5B)

Environmental insult, Time/Ageing

Senescent TII Cell

Activated fibroblast Myofibroblast differentiation Deposition of pathologic matrix

apoptosis

Critically short telomere’s

Clinical Relevance: IPF Comorbidities

  • Family history
  • Early Greying (< age 30) of hair may be clue to

telomere dysfunction, IPF

  • Bone marrow abnormalities

– Macrocytic anemia – Myelodysplastic syndrome

  • Predisposition to cancer
  • Co-morbidity of cirrhosis

Clinical Relevance: Management

  • Engage in behaviors that maintain telomere

length

– Aerobic exercise – De-stress your life, increase social support – Healthy diet, antioxidants, fish oil

  • Engage in behaviors that limit risk for injury to

the lung

– Avoid pollution – Vaccinate – No smoking